Earnings Ahead

AQST - Aquestive Therapeutics

1.66 0

Aquestive Therapeutics

Aquestive Therapeutics

About

Profile


Headquarters

Warren Township, New Jersey, United States


Intraday

High
-
Low
-

52-week

High
-
Low
-

AQST



 
...

Available for logged in users only.



The multiple price alert feature will smartly add or remove $1 if your alert was hit.
It's only available if you are logged in, a V.I.P. member or if you are using the AI chrome extension.

Contact us via Twitter if you are interested in trying it out.
  • Aquestive Therapeutics GAAP EPS of -$0.03 beats by $0.09, revenue of $13M beats by $1.49M
  • Aquestive Therapeutics Q3 2023 Earnings Preview
  • Aquestive Therapeutics weighs raising 2023 outlook
  • Aquestive spikes as FDA rejects ARS Pharma’s epinephrine spray
  • Aquestive Therapeutics GAAP EPS of -$0.10 beats by $0.01, revenue of $13.24M beats by $2.23M
  • Aquestive Therapeutics Q2 2023 Earnings Preview
  • Aquestive Therapeutics releases positive clinical data on anaphylm for anaphylaxis treatment
  • Aquestive Therapeutics reports Q1 results, raises FY 2023 revenue guidance
  • Aquestive Therapeutics Q1 2023 Earnings Preview
  • Aquestive receives conditional FDA approval for proprietary name Anaphylm for lead candidate AQST-109
  • Aquestive, Pharmanovia add territories to market seizure drug Libervant
  • Aquestive upgraded at Wedbush after Q4 cash update
  • Aquestive Therapeutics GAAP EPS of -$0.23 in-line, revenue of $10.68M beats by $0.26M
  • Aquestive Therapeutics FY 2022 Earnings Preview
  • Aquestive Therapeutics GAAP EPS of -$0.23 beats by $0.07, revenue of $11.46M beats by $0.42M
  • Aquestive out licenses anti-seizure therapy to Assertio unit
  • Aquestive Therapeutics receives positive FDA response for AQST-109 epinephrine for severe allergic reaction
  • Aquestive Therapeutics, Pharmanovia ink licensing & supply pact for Libervant buccal film
  • Aquestive adds 20% as epinephrine sublingual film outperforms autoinjector
  • SRNE, LGVN and MOB among premarket gainers
PEERS
/XLV

XLV

Date Price Open High Low Vol Change ER
Sep 27, 2023 1.52 1.52
1.57
1.49
216K -0.65%
Sep 26, 2023 1.53 1.5
1.58
1.5
179K 2%
Sep 25, 2023 1.5 1.6
1.61
1.48
278K -5.06%
Sep 22, 2023 1.58 1.63
1.63
1.55
248K -3.07%
Sep 21, 2023 1.63 1.67
1.67
1.54
532K -4.68%
 
Sep 20, 2023 1.71 1.65
1.78
1.61
808K 11.76%
Sep 19, 2023 1.53 1.54
1.57
1.5
187K -1.29%
Sep 18, 2023 1.55 1.62
1.65
1.55
170K -4.32%
Sep 15, 2023 1.62 1.61
1.64
1.56
340K 0.62%
Sep 14, 2023 1.61 1.66
1.72
1.58
179K -3.01%
Sep 13, 2023 1.66 1.68
1.78
1.64
233K 0%
Sep 12, 2023 1.66 1.57
1.7
1.56
246K 5.73%
Sep 11, 2023 1.57 1.49
1.66
1.47
251K 4.67%
Sep 8, 2023 1.5 1.58
1.58
1.47
222K -5.06%
Sep 7, 2023 1.58 1.55
1.62
1.52
234K 0%
Sep 6, 2023 1.58 1.64
1.64
1.57
284K -4.24%
Sep 5, 2023 1.65 1.67
1.67
1.63
153K -1.2%
Sep 1, 2023 1.67 1.65
1.69
1.63
108K 1.83%
Aug 31, 2023 1.64 1.65
1.69
1.63
118K -0.61%
Aug 30, 2023 1.65 1.67
1.7
1.65
128K -2.94%
Aug 29, 2023 1.7 1.71
1.77
1.69
137K -1.16%
Aug 28, 2023 1.72 1.79
1.79
1.7
173K -3.91%
Aug 25, 2023 1.79 1.8
1.82
1.73
201K 0%
Aug 24, 2023 1.79 1.8
1.84
1.76
123K 0%
Aug 23, 2023 1.79 1.76
1.86
1.71
178K 1.70%
Aug 22, 2023 1.76 1.82
1.82
1.69
204K -0.56%
Aug 21, 2023 1.77 1.74
1.83
1.73
167K 1.72%
Aug 18, 2023 1.74 1.74
1.8
1.63
252K 0%
Aug 17, 2023 1.74 1.79
1.86
1.73
215K -4.4%
Aug 16, 2023 1.82 1.85
1.89
1.81
167K -1.62%
Aug 15, 2023 1.85 1.82
1.97
1.82
246K 0%
Aug 14, 2023 1.85 1.92
1.92
1.83
339K -4.64%
Aug 11, 2023 1.94 1.93
1.96
1.88
236K -0.51%
Aug 10, 2023 1.95 2.01
2.09
1.92
365K -2.99%
Aug 9, 2023 2.01 1.97
2.06
1.94
246K 3.61%
Aug 8, 2023 1.94 2.17
2.17
1.77
768K -5.37%
Aug 7, 2023 2.05 2.06
2.07
1.89
672K -1.91%
Aug 4, 2023 2.09 2.22
2.24
2.01
514K -4.13%
Aug 3, 2023 2.18 2.2
2.23
2.15
305K 0.46%
Aug 2, 2023 2.17 2.24
2.29
2.09
564K -3.13%
Aug 1, 2023 2.24 2.28
2.28
2.08
631K 2.28%
Jul 31, 2023 2.19 2
2.27
2
1.4M 14.06%
Jul 28, 2023 1.92 1.75
1.93
1.72
973K 12.94%
Jul 27, 2023 1.7 1.71
1.78
1.68
407K 0%
Jul 26, 2023 1.7 1.6
1.71
1.59
309K 6.25%
Jul 25, 2023 1.6 1.56
1.65
1.56
373K 3.23%
Jul 24, 2023 1.55 1.56
1.66
1.55
319K -1.9%
Jul 21, 2023 1.58 1.6
1.61
1.53
225K -1.25%
Jul 20, 2023 1.6 1.69
1.69
1.59
287K -4.76%
Jul 19, 2023 1.68 1.65
1.73
1.63
235K 2.44%
Jul 18, 2023 1.64 1.62
1.66
1.59
186K 1.86%
Jul 17, 2023 1.61 1.56
1.65
1.53
300K 3.21%
Jul 14, 2023 1.56 1.63
1.65
1.56
294K -4.88%
Jul 13, 2023 1.64 1.65
1.67
1.61
231K 1.23%
Jul 12, 2023 1.62 1.6
1.67
1.6
313K 0.62%
Jul 11, 2023 1.61 1.66
1.66
1.59
284K -2.42%
Jul 10, 2023 1.65 1.65
1.7
1.59
264K -0.6%
Jul 7, 2023 1.66 1.69
1.71
1.61
273K -2.35%
Jul 6, 2023 1.7 1.68
1.74
1.6
409K 2.41%
Jul 5, 2023 1.66 1.61
1.78
1.58
883K 0%